We not only reveal an intrinsic role of the, AR in suppressing innate immunity in malignant epithelial cells of the prostate, but mechanistically, we also identify IKBKE eRNA and HDAC2 as 2 key effectors in mediating the immunosuppressive activity of the AR in prostate cancer. Here, IKBKE is linked to prostate carcinoma.